scholarly article | Q13442814 |
P356 | DOI | 10.1023/A:1012110724604 |
P698 | PubMed publication ID | 9210198 |
P2093 | author name string | B. D. Anderson | |
M. E. Morgan | |||
D. Singhal | |||
P2860 | cites work | Uptake kinetics of 2',3'-dideoxyinosine into brain and cerebrospinal fluid of rats: intravenous infusion studies | Q49045512 |
Dose-dependent brain delivery of zidovudine through the use of a zidovudine chemical delivery system | Q71536639 | ||
Role of altered metabolism in dideoxynucleoside pharmacokinetics. Studies of 2'-beta-fluoro-2',3'-dideoxyinosine and 2'-beta-fluoro-2',3'-dideoxyadenosine in rats | Q71731685 | ||
A STUDY OF THE TISSUE DISTRIBUTION OF ADENOSINE DEAMINASE IN SIX MAMMAL SPECIES | Q78342778 | ||
Molecular targets for AIDS therapy | Q28323494 | ||
Potential anti-AIDS drugs. Lipophilic, adenosine deaminase-activated prodrugs | Q28327907 | ||
Acid-stable 2'-fluoro purine dideoxynucleosides as active agents against HIV | Q28329208 | ||
Incorporation of analog purine nucleosides into the formed elements of human blood: erythrocytes, platelets, and lymphocytes | Q34063521 | ||
Metabolism of 2',3'-dideoxyinosine (ddI) in human blood | Q34402837 | ||
Central nervous system targeting of 2',3'-dideoxyinosine via adenosine deaminase-activated 6-halo-dideoxypurine prodrugs | Q36757759 | ||
The AIDS dementia complex | Q39535506 | ||
Antiviral therapy in human immunodeficiency virus infections. Current status (Part I). | Q40487127 | ||
Understanding the AIDS dementia complex (ADC). The challenge of HIV and its effects on the central nervous system | Q40718386 | ||
Current use of anti-HIV drugs in AIDS. | Q40863354 | ||
Enhancement by 2'-deoxycoformycin of the 5'-phosphorylation and anti-human immunodeficiency virus activity of 2',3'-dideoxyadenosine and 2'-beta-fluoro-2',3'-dideoxyadenosine. | Q41430419 | ||
2'-Fluoro-2',3'-dideoxyarabinosyladenine: a metabolically stable analogue of the antiretroviral agent 2',3'-dideoxyadenosine | Q41739422 | ||
2',3'-Dideoxy-2'-fluoro-ara-A. An acid-stable purine nucleoside active against human immunodeficiency virus (HIV). | Q42219490 | ||
Dideoxycytidine alone and in an alternating schedule with zidovudine in children with symptomatic human immunodeficiency virus infection | Q43514070 | ||
Effect of continuous intravenous infusion of zidovudine (AZT) in children with symptomatic HIV infection | Q44134576 | ||
Initial studies on the cellular pharmacology of 2',3'-dideoxyadenosine, an inhibitor of HTLV-III infectivity | Q44304958 | ||
Dideoxyinosine in Children with Symptomatic Human Immunodeficiency Virus Infection | Q45860738 | ||
Adenosine metabolism in microvessels from heart and brain | Q48417388 | ||
Brain, Blood, and Cerebrospinal Fluid Distribution of a Zidovudine Chemical Delivery System in Rabbits | Q48663341 | ||
Probenecid enhances central nervous system uptake of 2',3'-dideoxyinosine by inhibiting cerebrospinal fluid efflux. | Q48712713 | ||
Localization of purine metabolizing enzymes in bovine brain microvessel endothelial cells: an enzymatic blood-brain barrier for dideoxynucleosides? | Q48846114 | ||
P433 | issue | 6 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | brain tissue | Q11850260 |
P304 | page(s) | 786-792 | |
P577 | publication date | 1997-06-01 | |
P1433 | published in | Pharmaceutical Research | Q7180737 |
P1476 | title | Role of brain tissue localized purine metabolizing enzymes in the central nervous system delivery of anti-HIV agents 2'-beta-fluoro-2',3'-dideoxyinosine and 2'-beta-fluoro-2',3'-dideoxyadenosine in rats | |
P478 | volume | 14 |
Q33933498 | Development and optimization of anti-HIV nucleoside analogs and prodrugs: A review of their cellular pharmacology, structure-activity relationships and pharmacokinetics |
Q73850558 | Investigation of distribution, transport and uptake of anti-HIV drugs to the central nervous system |
Q74511156 | Optimization of the local inhibition of intestinal adenosine deaminase (ADA) by erythro-9-(2-hydroxy-3-nonyl)adenine: enhanced oral delivery of an ADA-activated prodrug for anti-HIV therapy |
Q37193593 | Progress in drug delivery to the central nervous system by the prodrug approach. |
Search more.